Authors: GALLAGHER M ALLEN SL STEVENSON J HILLER K OMARA V VELAGAPUDI R MITCHELL E VILLALONA M VANECHO D JAKIMOWICZ K ALLEN LF FISCHKOFF S ODWYER PJ

Citation: M. Gallagher et al., PHASE-I TRIAL OF THE DOLASTATIN-15 ANALOG LU-103793 (CEMADOTIN) EVERYOTHER DAY FOR 3 DOSES, Annals of oncology, 9, 1998, pp. 386-386

Authors: LICHTMAN SM CASACELLA P BUDMAN DR WILLIAMS G EISENBERG P DAMICO P OMARA V MUSGRAVE K ETCUBANAS E

Citation: Sm. Lichtman et al., DEVELOPMENT OF A FLUDARABINE PHOSPHATE (FAMP) DOSING FORMULA IN PATIENTS WITH RENAL-INSUFFICIENCY BASED ON A PHARMACOKINETIC (PK) STUDY IN PATIENTS WITH AND WITHOUT RENAL IMPAIRMENT, British Journal of Haematology, 102(1), 1998, pp. 245-245

Authors: BUDMAN DR WEISELBERG L OMARA V

Citation: Dr. Budman et al., SEVERE NEUROTOXICITY IN VINORELBINE-PACLITAXEL COMBINATIONS, Journal of the National Cancer Institute, 89(1), 1997, pp. 87-88

Authors: KOLITZ JE OMARA V WILLEMZE R POYNTON CH JAEGER U BRODY J SCHULMAN P

Citation: Je. Kolitz et al., TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) WITH CAMPATH-1H - INITIAL OBSERVATIONS, Blood, 84(10), 1994, pp. 10000301-10000301